Sumitomo Chemical Europe

Sumitomo-Chemical-Europe.jpg

Sumitomo Chemical provides high-quality oligonucleotides as drug substance for nucleic acid drugs to various customers.

We offer an agile response to your nucleic acid drug discovery and development, based on the same trust and proven technology that we have cultivated in the manufacture of small-molecule API for more than 40 years.

Latest Content

Investing in high-purity guide RNA to unlock the power of CRISPR therapies

Investing in high-purity guide RNA to unlock the power of CRISPR therapies

Paid for and content provided by Sumitomo Chemical Europe

The world urgently needs new manufacturing capabilities to realise the huge potential of genome editing therapy. Equipped with CRISPR-Cas9 technology, researchers have revealed opportunities to address major unmet medical needs through genome editing and...